Nanoparticles Derived from Tea Leaves Destroy Lung Cancer Cells
Nanoparticles derived from tea leaves inhibit the growth of lung cancer cells, destroying up to 80% of them, new research by a joint Swansea University and Indian team has shown.
The team made the discovery while they were testing out a new method of producing a type of nanoparticle called quantum dots. These are tiny particles which measure less than 10 nanometres. A human hair is 40,000 nanometres thick.
Although nanoparticles are already used in healthcare, quantum dots have only recently attracted researchers' attention. Already they are showing promise for use in different applications, from computers and solar cells to tumour imaging and treating cancer.
Quantum dots can be made chemically, but this is complicated and expensive and has toxic side effects. The Swansea-led research team were therefore exploring a non-toxic plant-based alternative method of producing the dots, using tea leaf extract.
Tea leaves contain a wide variety of compounds, including polyphenols, amino acids, vitamins and antioxidants. The researchers mixed tea leaf extract with cadmium sulphate (CdSO4) and sodium sulphide (Na2S) and allowed the solution to incubate, a process which causes quantum dots to form. They then applied the dots to lung cancer cells.
Tea leaves are a simpler, cheaper and less toxic method of producing quantum dots, compared with using chemicals, confirming the results of other research in the field.
Quantum dots produced from tea leaves inhibit the growth of lung cancer cells. They penetrated into the nanopores of the cancer cells and destroyed up to 80% of them. This was a brand new finding, and came as a surprise to the team.
The research, published in Applied Nano Materials, is a collaborative venture between Swansea University experts and colleagues from two Indian universities.
Dr Sudhagar Pitchaimuthu of Swansea University, lead researcher on the project, and a Ser Cymru-II Rising Star Fellow, said:
"Our research confirmed previous evidence that tea leaf extract can be a non-toxic alternative to making quantum dots using chemicals.
The real surprise, however, was that the dots actively inhibited the growth of the lung cancer cells. We hadn't been expecting this.
The CdS quantum dots derived from tea leaf extract showed exceptional fluorescence emission in cancer cell bioimaging compared to conventional CdS nanoparticles.
Quantum dots are therefore a very promising avenue to explore for developing new cancer treatments.
They also have other possible applications, for example in anti-microbial paint used in operating theatres, or in sun creams."
Dr Pitchaimuthu outlined the next steps for research:
"Building on this exciting discovery, the next step is to scale up our operation, hopefully with the help of other collaborators. We want to investigate the role of tea leaf extract in cancer cell imaging, and the interface between quantum dots and the cancer cell.
We would like to set up a "quantum dot factory" which will allow us to explore more fully the ways in which they can be used."
This article has been republished from materials provided by Swansea University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE